Delivery Order SPE2DB20D3103-SPE2DB22FM9Z9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,429.96 Firm Fixed Price Delivery Order covers the supply of 4,562,239,834 units of Epinephrine 0.3 mg Auto-Injectors for a period ending on September 21, 2023. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Cencora, Inc., doing business as Amerisourcebergen, holds...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,113.94 firm fixed-price delivery order is for the procurement of 4,560,797,275 units of Epinephrine 0.3 mg auto-injectors, with a period of performance through May 3, 2023. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical that provides...
- This federal contract award, valued at $8,464.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4,562,581,703 units of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,556,637,067 Epinephrine 0.3 mg auto-injectors. The firm-fixed-price contract, valued at $3,954.76, has a period of performance through March 22, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,743,798 units of Epinephrine 0.15 mg auto-injectors. The Delivery Order contract, valued at $1,953.85, has a firm fixed price and an ultimate completion date of February 23, 2024. The contract was awarded on February 22, 2024 and did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,373.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,556,974,597 units of Epinephrine 0.3 mg auto-injectors. This contract has an ultimate completion date of April 25, 2022 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,889.12 firm-fixed-price delivery order is for the supply of Epinephrine 0.15 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,389,079 epinephrine 0.3 mg auto-injectors. The $1,315.28 fixed-price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen is a subsidiary of the larger Cencora, Inc. parent company. This award is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.88, is for the delivery of epinephrine 0.15 mg auto-injectors and has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a federal contractor. Cencora, Inc. holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.15 mg auto-injectors. The $1,046.71 firm fixed-price delivery order was issued under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM9Z9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,556,560,954 units of Epinephrine 0.15 mg auto-injectors. The Firm Fixed Price delivery order, valued at $2,430.89, has a completion date of March 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). This contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/14/22 |